A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
Clinical trial NCT07767474 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07767474
- Sponsor
- Antares Therapeutics, Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-10-28
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.